Fidelity Investments
ACHV icon

Fidelity Investments’s Achieve Life Sciences ACHV Stock Holding History

Fidelity Investments’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116K Buy
17,707
+11,812
+200% +$56.3K ﹤0.01% 3905
2026
Q1 		$17.3K Sell
5,895
-618
-9% -$2.74K ﹤0.01% 4572
2025
Q4 		$32.4K Sell
6,513
-473
-7% -$2.06K ﹤0.01% 4285
2025
Q3 		$22K Sell
6,986
-2,254
-24% -$6.19K ﹤0.01% 4316
2025
Q2 		$20.9K Buy
9,240
+7,302
+377% +$20.8K ﹤0.01% 4263
2025
Q1 		$5.17K Sell
1,938
-637
-25% -$1.98K ﹤0.01% 4689
2024
Q4 		$9.06K Buy
2,575
+518
+25% +$2.35K ﹤0.01% 4494
2024
Q3 		$9.75K Buy
+2,057
New +$9.4K ﹤0.01% 4435
2024
Q1 		– Sell
-82
Closed -$338 – 5340
2023
Q4 		$338 Buy
+82
New +$357 ﹤0.01% 4843
2021
Q3 		– Sell
-1
Closed – – 4261
2021
Q2 		$0 Buy
+1
New +$10 ﹤0.01% 4169
2015
Q4 		– Sell
-34
Closed -$168K – 2726
2015
Q3 		$168K Sell
34
-150
-82% -$904K ﹤0.01% 2688
2015
Q2 		$944K Sell
184
-40
-18% -$198K ﹤0.01% 2559
2015
Q1 		$1.06M Sell
224
-39
-15% -$192K ﹤0.01% 2510
2014
Q4 		$1.32M Buy
263
+65
+33% +$318K ﹤0.01% 2506
2014
Q3 		$1.16M Buy
198
+5
+3% +$34.7K ﹤0.01% 2519
2014
Q2 		$1.58M Buy
193
+161
+503% +$1.98M ﹤0.01% 2438
2014
Q1 		$817K Sell
32
-72
-69% -$1.77M ﹤0.01% 2498
2013
Q4 		$1.91M Buy
104
+4
+4% +$70.2K ﹤0.01% 2354
2013
Q3 		$2.03M Sell
100
-110
-52% -$2.28M ﹤0.01% 2346
2013
Q2 		$4.52M Buy
+210
New +$4.7M ﹤0.01% 2163

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Fidelity Investments's ACHV Position: Q2 2026 in Review

Fidelity Investments increased its Achieve Life Sciences (ACHV) stake by 200% in Q2 2026, buying an estimated $56.3K and bringing the position to 17,707 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #3905.

Fidelity Investments first reported a position in ACHV in Q2 2013 and has held it in 20 quarters since. The position peaked at $4.52M in Q2 2013. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Fidelity Investments held 17,707 shares of Achieve Life Sciences worth $116K as of Q2 2026.
  • Fidelity Investments bought 11,812 Achieve Life Sciences shares in Q2 2026, an estimated $56.3K.
  • Achieve Life Sciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3905 holding.
  • Fidelity Investments first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 20 quarters since.
  • Fidelity Investments's Achieve Life Sciences position peaked at $4.52M in Q2 2013.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.